Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_assertion type Assertion NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_head.
- NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_assertion description "[Moreover, weak expression of ADAM23 in methylated cancer cells increased after treatment with 5-aza-2'-deoxycytidine (5-Aza-2'-dC), confirming that methylation was responsible for the gene downregulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_provenance.
- NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_assertion evidence source_evidence_literature NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_provenance.
- NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_assertion SIO_000772 21429053 NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_provenance.
- NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_assertion wasDerivedFrom befree-20150227 NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_provenance.
- NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_assertion wasGeneratedBy ECO_0000203 NP804485.RAsRQsUjYi57mqs-QCkpXzRW2LOL7_TDumB96VdSaHRMM130_provenance.